Nanobiotix-J&J Therapy Shows Promise In Tough Head And Neck Cancer

benzinga.com/news/health-care/25/09/47951061/nanobiotix-jj-therapy-shows-promise-in-tough-head-and-neck-cancer

Nanobiotix SA (NASDAQ:NBTX) on Tuesday announced updated data from cohorts 1 and 2 of Study 1100 Phase 1 dose escalation and expansion trial evaluating JNJ-1900 (NBTXR3) activated by radiation therapy (RT) followed by anti-PD-1 immune checkpoint inhibitors (ICI) in patients with…

This story appeared on benzinga.com, 2025-09-30 17:43:20.
The Entire Business World on a Single Page. Free to Use →